Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
diterbitkan dalam: JAMA Oncology
tanggal publikasi: 2020-02-13
subyek utama: phase II clinical trial, pembrolizumab
Cites articles 23
- 2016-07-11
- 2011-11-08
Date
Judul
Artikel - wd:Q89693629